Posted on 08 September 2010 by admin
Watch-List for Thursday 9-9-10
We've been on fire with our alerts so far this week...
Both of our featured stocks, MBHS and TSAN had big days today after major news announcements this morning. It could just be the start for these two!
Volume Alert - MBHS
http://www.chartmoney.com/stockcharts.php/?ticker=mbhs&B1=Get+Quote
Skin Cancer Scanning Ltd. (SCS) is a medical device company pioneering the
development and commercialization of a revolutionary and proprietary imaging
system for the early detection and diagnosis of skin cancer.
OTCReporter.com, HotOTCChina.com, OTCPennystockreporter.com,
OTCPennypicks.com, and Chartpenny.com (the “Websites”) are owned by Oceanic
Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State")
(Oceanic and Garden State are collectively referred to herein as the "LLC
Companies) , both of which are New Jersey limited liability
corporations (the Websites and its owners, the LLC Companies, and their
affiliates, directors and officers and its immediate family members are referred
to in our Disclaimer as "OTCR" or "we" or "us" or "our"). Because we receive
monetary or securities compensation, most often in the form of
common stock (hereafter referred to as the "Shares") for our dissemination of
publicly disseminated information (the “Information”) regarding various issuers
of securities, we disclose our specific compensation herein and in our
individual reports of profiled issuers. The LLC Companies
received forty thousand dollars from a non-affiliate third party shareholder of MBHS Skin Cancer Scanning Ltd. in return for OTCR’s services to publicly and
electronically disseminate information pertaining to Skin Cancer Scanning
Ltd. The LLC Companies contracted to receive and
received twenty-five thousand dollars from a non-affiliate third party
shareholder of TSAN Truesport Alliance in return for OTCR’s services to publicly
and electronically disseminate information pertaining to Truesport
Alliance. It is imperative that all readers of the above
compensations disclosure carefully review our Disclaimer in its entirety, which
contains important information about penny stocks, our operations, the limited
nature of the Information and various risks attendant to the companies that we
profile, including that: (a) we receive our compensation in free trading shares,
which we will sell immediately upon their receipt as well as during the
dissemination of such Information or within hours, days, weeks or months
thereafter, or at any time; as a result, our selling activities will cause
significant volatility in the Issuer’s stock price and/or significantly depress
the Issuer’s stock price; (b) we will buy and sell the Shares in the open market
before, during or after the dissemination of the Information or at any time,
which will cause significant volatility in the Issuer’s stock price and/or
significantly depress or increase the Issuer’s stock price; (c) there is an
inherent and actual conflict of interest that exists between our Readers’
interests and our interests because we: (i) receive the Shares as compensation
for disseminating the Information and thereafter sell those Shares at any time
for monetary gain, including at the same time the Information is being
disseminated or shortly thereafter or at any time; and (ii) buy and sells the
Profiled Company’s shares in the open market at the same time or before the
Information is being disseminated or shortly after the dissemination of the
Information or at any time. Our gains from sale of the Shares may be
substantial.
| This message was sent from OTCReporter to Subscriber. It was sent from: OTCReporter.com, P.O. Box 273, Rumson, NJ 07760. You can modify/update your subscription via the link below. |
Email Marketing by
 |
|